Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma 2024-03-28 19:00
Tigermed Reports Full Year 2023 Results 2024-03-28 18:31
CARsgen Announced 2023 Annual Results 2024-03-27 20:50
Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development 2024-03-27 20:00
YolTech Therapeutics to Participate in 2024 Cell & Gene Meeting on the Mediterranean 2024-03-27 20:00
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology 2024-03-27 06:00
WuXi Biologics Reports Solid 2023 Annual Results 2024-03-26 21:53
Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients 2024-03-26 21:00
TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B Patients 2024-03-26 20:00
Full-Life Technologies Achieves Regulatory Milestone with Nuclear Permit, Advancing Radioisotope Facility Construction 2024-03-26 08:00
GC Genome to Present New Data at AACR 2024 2024-03-25 21:00
100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Capsule (UTD2) for the Treatment of Gastric Cancer 2024-03-21 20:30
FDA Grants Orphan Drug Designation to Cevidoplenib for ITP 2024-03-21 20:00
Biosion to Present Three Posters at the 2024 AACR Meeting 2024-03-21 19:00
HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update 2024-03-21 19:00
Mabwell Presented IDDC™ Platform Technology and ADC Drug Development Achievements at the 14th World ADC London 2024-03-21 14:11
Origin Agritech Announces Breakthrough in High-Yield Corn Production Through Gene Editing 2024-03-20 20:00
SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential 2024-03-19 22:00
Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical Study 2024-03-19 10:24
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC 2024-03-19 08:00
1 4 5 6 7 8 204